The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Time from randomization to first subsequent induction/salvage therapy (ST) in patients with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL) treated with inotuzumab ozogamicin (InO) in the phase 3 INO-VATE trial.
 
Elias Jabbour
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Amgen; Astellas Pharma; Bristol-Myers Squibb; Incyte; Pfizer; Takeda
Research Funding - Abbvie; Adaptive Biotechnologies; Amgen; Pfizer; Takeda
 
Matthias Stelljes
Honoraria - Amgen; Jazz Pharmaceuticals; Novartis; Pfizer
Consulting or Advisory Role - MSD; Pfizer
Research Funding - Pfizer
 
Anjali S. Advani
Honoraria - EUSA Pharma; Pfizer; Sigma-Tau
Consulting or Advisory Role - Glycomimetics; Novartis; Pfizer; Seagen
Research Funding - KaloBios (Inst); Millennium (Inst); Pfizer (Inst); Seagen (Inst)
 
Daniel J. DeAngelo
Consulting or Advisory Role - Amgen; ARIAD; Bristol-Myers Squibb; Celgene; Immunogen; Incyte; Novartis; Pfizer; Shire
 
Tao Wang
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Alexander Neuhof
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Erik Vandendries
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Hagop M. Kantarjian
Honoraria - Abbvie; Actinium Pharmaceuticals; Agios; Amgen; Immunogen; Orsenix; Pfizer; Takeda
Research Funding - Abbvie (Inst); Agios (Inst); Amgen (Inst); ARIAD (Inst); Astex Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Cyclacel (Inst); Daiichi Sankyo (Inst); Immunogen (Inst); Jazz Pharmaceuticals (Inst); Novartis (Inst); Pfizer (Inst)